WE'RE PASSIONATE ABOUT PHAGE DISPLAY AND THE DISCOVERIES IT MAKES POSSIBLE.
We founded Cell Origins to do discovery differently—keeping the science close to those who've spent decades mastering it. As founders, we lead every project, using phage display to uncover ligands that reflect the quality this company was built on.
MANAGEMENT
At Cell Origins we are passionate about phage display! Our founders are all alumni from the University of Missouri, the birthplace of phage display technology and have been trained by the leading experts in the field.
Leann Kuhlmann-Qi
Leann Kuhlmann-Qi (M.B.A.) brings extensive expertise in managing business operations for early-stage biotech firms. She founded Kuhlmann Consulting, handling projects like grant administration and developing a financial product tied to a New York Times bestseller. At Cell Origins LLC, she oversees business operations and drives strategic development, leveraging her skills to advance the company's goals.
Jessica Newton-Northup
With over 20 years of experience in phage display technology, has conducted numerous selections to identify cancer-targeting ligands and biomarkers, contributing to approximately 30 publications and multiple grants. She led a team at an early-stage pharmaceutical company to address peptide drug development challenges. At Cell Origins LLC, she focuses on advancing phage display methods and cell line verification technologies.
Mette Soendergaard
Mette Soendergaard (Ph.D.) has over ten years of experience leading phage display research, pioneering a two-tier selection protocol and a method targeting ovarian cancer subpopulations. She has published several articles on peptides targeting cancerous tissues and biomarkers. At Cell Origins LLC, she drives innovation in phage display technologies, enhancing selection protocols, cell line verification, and biomarker isolation.
FOUNDED BY METTE, JESSICA AND LEANN IN 2019.
Years earlier, Dr. Mette Soendergaard and Jessica Newton Northup formed and maintained a collaborative relationship while at the University of Missouri, the birthplace of phage display technology. Here, they developed a passion for phage display technology and development of phage-based methods that they now bring to Cell Origins LLC.
The passion of our team for phage-based solutions brought us to address the growing challenge identified by the National Institute of Health; that is the need for a product to verify the identity and phenotype of cell lines. Thus, we are currently developing a phage-based product for identification and phenotypic characterization of commonly used cell lines.